FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Johannes Bonfrer

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
György Sölétormos; Catharine M Sturgeon; Bengt Tholander; Malgorzata K Tuxen; Vivian Barak; Patrick M Bossuyt; Eleftherios P Diamandis; Michael J Duffy; Massimo Gion; Daniel F Hayes; Per Hyltoft Petersen; Rolf M Lamerz; Dorte Lisbet Nielsen; Paul Sibley; Johannes M G Bonfrer
Design of tumor biomarker-monitoring trials: a proposal by the European Group on Tumor Markers.
Catharina M Korse; Theodora C Linders; Babs G Taal; Marie-Louise F Van Velthuysen; Andrew Vincent; Paul Baas; Johanna C G M Buning-Kager; Johannes M G Bonfrer
Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragments.
Catharina M Korse; Warner Prevoo; Paul Baas; Johannes M G Bonfrer; Babs G Taal
Increase of angiogenic growth factors after hepatic artery embolization in patients with neuroendocrine tumours.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Johannes Bonfrer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: György Sölétormos; Catharine M Sturgeon; Bengt Tholander; Malgorzata K Tuxen; Vivian Barak; Patrick M Bossuyt; Eleftherios P Diamandis; Michael J Duffy; Massimo Gion; Daniel F Hayes; Per Hyltoft Petersen; Rolf M Lamerz; Dorte Lisbet Nielsen; Paul Sibley; Johannes M G Bonfrer
Design of tumor biomarker-monitoring trials: a proposal by the European Group on Tumor Markers.
Clinical chemistry 2013;59(1):52-9.
2012: Catharina M Korse; Theodora C Linders; Babs G Taal; Marie-Louise F Van Velthuysen; Andrew Vincent; Paul Baas; Johanna C G M Buning-Kager; Johannes M G Bonfrer
Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragments.
European journal of cancer (Oxford, England : 1990) 2012;48(5):662-71.
2011: Catharina M Korse; Warner Prevoo; Paul Baas; Johannes M G Bonfrer; Babs G Taal
Increase of angiogenic growth factors after hepatic artery embolization in patients with neuroendocrine tumours.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2011;32(4):647-52.
2010: Tjeerd S Aukema; Renato A Valdés Olmos; Catharina M Korse; Bin B R Kroon; Michel W J M Wouters; Wouter V Vogel; Johannes M G Bonfrer; Omgo E Nieweg
Utility of FDG PET/CT and brain MRI in melanoma patients with increased serum S-100B level during follow-up.
Annals of surgical oncology 2010;17(6):1657-61.
2010: Barbara C van Munster; Johanna C Korevaar; Catharina M Korse; Johannes M G Bonfrer; Aeilko H Zwinderman; Sophia de Rooij
Serum S100B in elderly patients with and without delirium.
International journal of geriatric psychiatry 2010;25(3):234-9.
2009: Catharina M Korse; Babs G Taal; Cornelis A de Groot; Robert H Bakker; Johannes M G Bonfrer
Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(26):4293-9.
2009: Marie-Christine W Gast; Carla H van Gils; Lodewyk Wessels; Nathan Harris; Johannes M G Bonfrer; Emiel J Th Rutgers; Jan H M Schellens; Jos H Beijnen
Serum protein profiling for diagnosis of breast cancer using SELDI-TOF MS.
Oncology reports 2009;22(1):205-13.
2009: Barbara C van Munster; Catharina M Korse; Sophia de Rooij; Johannes M G Bonfrer; Aeilko H Zwinderman; Johanna C Korevaar
Markers of cerebral damage during delirium in elderly patients with hip fracture.
BMC neurology 2009;9():21.
2009: Marie-Christine W Gast; Carla H van Gils; Lodewyk F A Wessels; Nathan Harris; Johannes M G Bonfrer; Emiel J Th Rutgers; Jan H M Schellens; Jos H Beijnen
Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS).
Clinical chemistry and laboratory medicine : CCLM / FESCC 2009;47(6):694-705.
2009: Catharina M Korse; Johannes M G Bonfrer; Marc van Beurden; René H M Verheijen; Matti A Rookus
Estradiol and testosterone levels are lower after oophorectomy than after natural menopause.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2009;30(1):37-42.
2009: Catharina M Korse; Johannes M G Bonfrer; Neil K Aaronson; Augustinus A M Hart; Babs G Taal
Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.
Neuroendocrinology 2009;89(3):296-301.
2008: Alina Vrieling; Matti A Rookus; Ellen Kampman; Johannes M G Bonfrer; Astrid J Bosma; Annemieke Cats; Jaap van Doorn; Catharina M Korse; Ben J M Witteman; Flora E van Leeuwen; Laura J van't Veer; Dorien W Voskuil
No effect of red clover-derived isoflavone intervention on the insulin-like growth factor system in women at increased risk of colorectal cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(10):2585-93.
2008: L H M Smit; O E Nieweg; W J Mooi; Johannes M G Bonfrer; John B A G Haanen; B B R Kroon; G C De Gast
Value of serum S-100B for prediction of distant relapse and survival in stage III B/C melanoma.
Anticancer research 2008;28(4C):2297-302.
2008: Anne Zeleniuch-Jacquotte; Yian Gu; Peter F Bruning; Johannes M G Bonfrer; Karen L Koenig; Alan A Arslan; Paolo Toniolo; Roy E Shore
Re: C-reactive protein and risk of breast cancer.
Journal of the National Cancer Institute 2008;100(6):443-4; author reply 444-5.
2008: michel van den heuvel; Catharina M Korse; Johannes M G Bonfrer; Paul Baas
Non-invasive diagnosis of pleural malignancies: the role of tumour markers.
Lung cancer (Amsterdam, Netherlands) 2008;59(3):350-4.
2008: Dorien W Voskuil; Alina Vrieling; Catharina M Korse; Jos H Beijnen; Johannes M G Bonfrer; Jaap van Doorn; Reinie Kaas; Hester S A Oldenburg; Nicola S Russell; E J Th Rutgers; Senno Verhoef; Flora E van Leeuwen; Laura J van't Veer; Matti A Rookus
Effects of lycopene on the insulin-like growth factor (IGF) system in premenopausal breast cancer survivors and women at high familial breast cancer risk.
Nutrition and cancer 2008;60(3):342-53.
2007: Alina Vrieling; Dorien W Voskuil; Johannes M G Bonfrer; Catharina M Korse; Jaap van Doorn; Annemieke Cats; Annekatrien C Depla; Robin Timmer; Ben J M Witteman; Flora E van Leeuwen; Laura J van't Veer; Matti A Rookus; Ellen Kampman
Lycopene supplementation elevates circulating insulin-like growth factor binding protein-1 and -2 concentrations in persons at greater risk of colorectal cancer.
The American journal of clinical nutrition 2007;86(5):1456-62.
2007: Daniëlle A M Heideman; Tim Waterboer; Michael Pawlita; Pien Delis-van Diemen; Ingo Nindl; Joost A P Leijte; Johannes M G Bonfrer; Simon Horenblas; Chris J L M Meijer; Peter J F Snijders
Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(29):4550-6.
2007: Judith Y M N Engwegen; Niven Mehra; John B A G Haanen; Johannes M G Bonfrer; Jan H M Schellens; Emile E Voest; Jos H Beijnen
Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in new populations.
Laboratory investigation; a journal of technical methods and pathology 2007;87(2):161-72.
2007: Alina Vrieling; Matti A Rookus; Ellen Kampman; Johannes M G Bonfrer; Catharina M Korse; Jaap van Doorn; Johanna W Lampe; Annemieke Cats; Ben J M Witteman; Flora E van Leeuwen; Laura J van't Veer; Dorien W Voskuil
Isolated isoflavones do not affect the circulating insulin-like growth factor system in men at increased colorectal cancer risk.
The Journal of nutrition 2007;137(2):379-83.
2007: Guy S Missotten; Catharina M Korse; C van Dehn; T C Linders; Jan E E Keunen; Martine J Jager; Johannes M G Bonfrer
S-100B protein and melanoma inhibitory activity protein in uveal melanoma screening. A comparison with liver function tests.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2007;28(2):63-9.
2006: Stephanie T H Peeters; Wilma D Heemsbergen; Peter C M Koper; Wim L J van Putten; Annerie Slot; Michel F H Dielwart; Johannes M G Bonfrer; Luca Incrocci; Joos V Lebesque
Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(13):1990-6.
2006: Judith Y M N Engwegen; Helgi H Helgason; Annemieke Cats; Nathan Harris; Johannes M G Bonfrer; Jan H M Schellens; Jos H Beijnen
Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry.
World journal of gastroenterology : WJG 2006;12(10):1536-44.
2006: Sander Keijser; Guy S Missotten; Johannes M G Bonfrer; Didi de Wolff-Rouendaal; Martine J Jager; R J W De Keizer
Immunophenotypic markers to differentiate between benign and malignant melanocytic lesions.
The British journal of ophthalmology 2006;90(2):213-7.
2006: M C W Gast; Johannes M G Bonfrer; E J van Dulken; L de Kock; E J Th Rutgers; J H M Schellens; J H Beijnen
SELDI-TOF MS serum protein profiles in breast cancer: assessment of robustness and validity.
Cancer biomarkers : section A of Disease markers 2006;2(6):235-48.
2005: Lennard Dekker; Willem Boogerd; Günther Stockhammer; Johannes C Dalebout; Ivar Siccama; Pingpin Zheng; Johannes M G Bonfrer; Jan J Verschuuren; Guido Jenster; Marcel M Verbeek; Theo M Luider; Peter A E Sillevis Smitt
MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer.
Molecular & cellular proteomics : MCP 2005;4(9):1341-9.
2005: Léonie H M Smit; Omgo E Nieweg; Catharina M Korse; Johannes M G Bonfrer; Bin B R Kroon
Significance of serum S-100B in melanoma patients before and after sentinel node biopsy.
Journal of surgical oncology 2005;90(2):66-9; discussion 69-70.
2005: Léonie H M Smit; Catharina M Korse; Augustinus A M Hart; Johannes M G Bonfrer; John B A G Haanen; J Martijn Kerst; Omgo E Nieweg; Gijsbert C De Gast
Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients.
European journal of cancer (Oxford, England : 1990) 2005;41(3):386-92.
2005: Léonie H M Smit; Catharina M Korse; Johannes M G Bonfrer
Comparison of four different assays for determination of serum S-100B.
The International journal of biological markers 2005;20(1):34-42.
2004: Johanna M Zuetenhorst; Catharina M Korse; Johannes M G Bonfrer; Ellen Peter; Cornelis B H W Lamers; Babs G Taal
Daily cyclic changes in the urinary excretion of 5-hydroxyindoleacetic acid in patients with carcinoid tumors.
Clinical chemistry 2004;50(9):1634-9.
2004: Johanna M Zuetenhorst; Catharina M Korse; Johannes M G Bonfrer; R H Bakker; Babs G Taal
Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease.
British journal of cancer 2004;90(11):2073-9.
2003: Guy S Missotten; Jos H Beijnen; Jan E E Keunen; Johannes M G Bonfrer
Proteomics in uveal melanoma.
Melanoma research 2003;13(6):627-9.
2003: Guy S Missotten; Nancy E M L Tang; Catharina M Korse; H Monique H Hurks; Didi de Wolff-Rouendaal; Jan E E Keunen; Martine J Jager; Johannes M G Bonfrer
Prognostic value of S-100-beta serum concentration in patients with uveal melanoma.
Archives of ophthalmology 2003;121(8):1117-9.
2003: G J J van Doornum; Catharina M Korse; J C G M Buning-Kager; Johannes M G Bonfrer; S Horenblas; Babs G Taal; J Dillner
Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites.
British journal of cancer 2003;88(7):1095-100.
2003: Johanna M Zuetenhorst; Johannes M G Bonfrer; Catharina M Korse; Rob Bakker; Harm van Tinteren; Babs G Taal
Carcinoid heart disease: the role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factor.
Cancer 2003;97(7):1609-15.
2003: A P Hamberg; Catharina M Korse; Johannes M G Bonfrer; Gijsbert C De Gast
Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanoma.
Melanoma research 2003;13(1):45-9.
2003: Marleen Kok; Johannes M G Bonfrer; Catharina M Korse; Daphne de Jong; Marie José Kersten
Serum soluble CD27, but not thymidine kinase, is an independent prognostic factor for outcome in indolent non-Hodgkin's lymphoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2003;24(1):53-60.
2003: Petra Stieber; Rafael Molina; Daniel W Chan; Herbert A Fritsche; Ralf Beyrau; Johannes M G Bonfrer; Xavier Filella; Terrie G Gornet; Torsten Hoff; Wolfram Jäger; Gerard J van Kamp; Dorothea Nagel; Klaus Peisker; Lori J Sokoll; Frédéric Troalen; Michael Untch; Ingrid Domke
Clinical evaluation of the Elecsys CA 15-3 test in breast cancer patients.
Clinical laboratory 2003;49(1-2):15-24.
2002: Serge van Ruth; Augustinus A M Hart; Johannes M G Bonfrer; Vic J Verwaal; Frans A N Zoetmulder
Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy.
Annals of surgical oncology 2002;9(10):961-7.
2002: Daniel L Baker; Patton Morrison; Brigitte Miller; Caroline A Riely; Betsy Tolley; Anneke M Westermann; Johannes M G Bonfrer; Evert Bais; Wouter H Moolenaar; Gabor Tigyi
Plasma lysophosphatidic acid concentration and ovarian cancer.
JAMA : the journal of the American Medical Association 2002;287(23):3081-2.
2001: P Stieber; Rafael Molina; Daniel W Chan; H A Fritsche; R Beyrau; Johannes M G Bonfrer; Xavier Filella; T G Gornet; Torsten Hoff; W Jäger; Gerard J van Kamp; Dorothea Nagel; K Peisker; Lori J Sokoll; Frédéric Troalen; Michael Untch; Ingrid Domke
Evaluation of the analytical and clinical performance of the Elecsys CA 15-3 immunoassay.
Clinical chemistry 2001;47(12):2162-4.
2001: Johannes M G Bonfrer; Catharina M Korse
Monitoring malignant melanoma with the S-100B tumour marker.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2001;158():149-57.
2000: Paolo Toniolo; Peter Bruning; Arslan Akhmedkhanov; Johannes M G Bonfrer; Karen L Koenig; Annekatrin Lukanova; Roy E Shore; Anne Zeleniuch-Jacquotte
Serum insulin-like growth factor-I and breast cancer.
International journal of cancer. Journal international du cancer 2000;88(5):828-32.
2000: Katja N Gaarenstroom; Gemma G Kenter; Johannes M G Bonfrer; Catharina M Korse; M J Van de Vijver; Gert Jan Fleuren; J Baptist Trimbos
Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
Gynecologic oncology 2000;77(1):164-70.
2000: Joost M Klaase; JC Swaanenburg; Hugo Schouwink; M N Sosef; Johannes M G Bonfrer; Frans A N Zoetmulder; E J Th Rutgers; Paul Baas
Monitoring of impending myocardial damage after pleuropneumonectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma using biochemical markers.
Photochemistry and photobiology 2000;71(3):351-4.
1999: Hugo Schouwink; Catharina M Korse; Johannes M G Bonfrer; Augustinus A M Hart; Paul Baas
Prognostic value of the serum tumour markers Cyfra 21-1 and tissue polypeptide antigen in malignant mesothelioma.
Lung cancer (Amsterdam, Netherlands) 1999;25(1):25-32.
1999: Johannes M G Bonfrer; Catharina M Korse
TPA and CA 15.3 measurements for breast cancer monitoring in a routine setting.
The International journal of biological markers 1999;14(1):40-4.
1998: Peter Bruning; Johannes M G Bonfrer; Robert Paridaens; Marianne A Nooij; Jan G M Klijn; Louk V A M Beex; J Bruynseels; Martine J Piccart
Vorozole (R83842) in the treatment of postmenopausal advanced breast cancer: relationship of serum levels of vorozole and clinical results (a study of the EORTC Breast Cancer Cooperative Group).
Anti-cancer drugs 1998;9(5):419-25.
1998: Johannes M G Bonfrer; Catharina M Korse; Omgo E Nieweg; Elaine M Rankin
The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma.
British journal of cancer 1998;77(12):2210-4.
1997: Johannes M G Bonfrer; Catharina M Korse; S P Israels
Serum S-100 has prognostic significance in malignant melanoma.
Anticancer research 1997;17(4B):2975-7.
1997: Johannes M G Bonfrer; J Hugo Schouwink; Catharina M Korse; Paul Baas
Cyfra 21-1 and TPA as markers in malignant mesothelioma.
Anticancer research 1997;17(4B):2971-3.
1997: Katja N Gaarenstroom; Johannes M G Bonfrer; Catharina M Korse; Gemma G Kenter; Peter Kenemans
Value of Cyfra 21-1, TPA, and SCC-Ag in predicting extracervical disease and prognosis in cervical cancer.
Anticancer research 1997;17(4B):2955-8.
1997: Anne Zeleniuch-Jacquotte; Peter Bruning; Johannes M G Bonfrer; Karen L Koenig; Roy E Shore; Mimi Y Kim; Bernard S Pasternack; Paolo Toniolo
Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women.
American journal of epidemiology 1997;145(11):1030-8.
1997: Johannes M G Bonfrer; Katja N Gaarenstroom; Catharina M Korse; BN Van Bunningen; Peter Kenemans
Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
Anticancer research 1997;17(3C):2329-34.
1997: Johannes M G Bonfrer; Catharina M Korse; Rob A Verstraeten; Gerard J van Kamp; Guus A M Hart; Peter Kenemans
Clinical evaluation of the Byk LIA-mat CA125 II assay: discussion of a reference value.
Clinical chemistry 1997;43(3):491-7.
1997: Johannes M G Bonfrer; T C Linders; P C Hageman; John Hilkens; Catharina M Korse; C F Molthoff
Effect of paclitaxel (Taxol) on CA 125 expression and release by ovarian cancer cell lines.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1997;18(4):232-40.
1997: Bart C Vrouenraets; Bin B R Kroon; Joost M Klaase; Johannes M G Bonfrer; Omgo E Nieweg; Gooike W van Slooten; JA van Dongen
Value of laboratory tests in monitoring acute regional toxicity after isolated limb perfusion.
Annals of surgical oncology 1997;4(1):88-94.
1996: E M Davelaar; Johannes M G Bonfrer; Rob A Verstraeten; Wim W ten Bokkel Huinink; Peter Kenemans
CA 125: a valid marker in ovarian carcinoma patients treated with paclitaxel?
Cancer 1996;78(1):118-27.
1995: Katja N Gaarenstroom; Johannes M G Bonfrer; Gemma G Kenter; Catharina M Korse; Augustinus A M Hart; J Baptist Trimbos; Theo J M Helmerhorst
Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer.
Cancer 1995;76(5):807-13.
1994: Johannes M G Bonfrer; Katja N Gaarenstroom; Gemma G Kenter; Catharina M Korse; Augustinus A M Hart; M P Gallee; Theo J M Helmerhorst; Peter Kenemans
Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancer.
Gynecologic oncology 1994;55(3 Pt 1):371-5.
1994: Katja N Gaarenstroom; Gemma G Kenter; Johannes M G Bonfrer; Catharina M Korse; M P Gallee; Augustinus A M Hart; M Müller; J Baptist Trimbos; Theo J M Helmerhorst
Prognostic significance of serum antibodies to human papillomavirus-16 E4 and E7 peptides in cervical cancer.
Cancer 1994;74(8):2307-13.
1994: Johannes M G Bonfrer; A W Baan; E Jansen; D Lentfer; Peter Kenemans
Technical evaluation of three second generation CA 125 assays.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1994;32(3):201-7.
1994: Johannes M G Bonfrer; E M Groeneveld; Catharina M Korse; A van Dalen; Lauran Oomen; D Ivanyi
Monoclonal antibody M3 used in tissue polypeptide-specific antigen assay for the quantification of tissue polypeptide antigen recognizes keratin 18.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1994;15(4):210-22.
1993: C M Thomas; T Wobbes; Johannes M G Bonfrer; J L Peterse; M Nap; L V Beex
[Tumor markers in screening, diagnosis and treatment of patients with breast carcinoma].
Nederlands tijdschrift voor geneeskunde 1993;137(46):2354-7.
1993: K L Koenig; Paolo Toniolo; Peter Bruning; Johannes M G Bonfrer; Roy E Shore; B S Pasternack
Reliability of serum prolactin measurements in women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1993;2(5):411-4.
1993: E H Hopman; Theo J M Helmerhorst; Johannes M G Bonfrer; Wim W ten Bokkel Huinink
Highly elevated serum CA 125 levels in a patient with cardiac failure.
European journal of obstetrics, gynecology, and reproductive biology 1993;48(1):71-3.
1992: nico van zandwijk; E Jassem; Johannes M G Bonfrer; Wolter J Mooi; H van Tinteren
Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
Seminars in oncology 1992;19(1 Suppl 2):37-43.
1992: Johannes M G Bonfrer; H M de Graaf; Willem Nooijen
Breast cancer mucin: an automated assay to detect mucus glycoproteins.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1992;13(3):162-7.
1990: C M de Ridder; Peter Bruning; Maria L Zonderland; Jos H H Thijssen; Johannes M G Bonfrer; Marinus A Blankenstein; IA Huisveld; W B Erich
Body fat mass, body fat distribution, and plasma hormones in early puberty in females.
The Journal of clinical endocrinology and metabolism 1990;70(4):888-93.
1990: nico van zandwijk; E Jassem; Johannes M G Bonfrer; H van Tinteren
Value of neuron specific enolase in early detection of relapse in small cell lung carcinoma.
European journal of cancer (Oxford, England : 1990) 1990;26(3):373-6.
1990: T M Mulders; Peter Bruning; Johannes M G Bonfrer
Prostate-specific antigen (PSA). A tissue-specific and sensitive tumor marker.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1990;16(1):37-41.
1989: Johannes M G Bonfrer; Peter Bruning; Willem Nooijen
A simple method for the measurement of the steroid fraction bound to sex hormone binding globulin in serum.
Journal of steroid biochemistry 1989;33(2):227-31.
1989: Peter Bruning; Johannes M G Bonfrer; Augustinus A M Hart; E van der Linden; M de Jong-Bakker; A J Moolenaar; Willem Nooijen
Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancer.
European journal of cancer & clinical oncology 1989;25(2):369-76.
1988: Peter Bruning; Johannes M G Bonfrer; Augustinus A M Hart; M de Jong-Bakker; D Linders; J van Loon; W J Nooyen
Tamoxifen, serum lipoproteins and cardiovascular risk.
British journal of cancer 1988;58(4):497-9.
1988: Peter Bruning; Johannes M G Bonfrer; A Ansink; Nicola S Russell; M de Jong-Bakker
Why is breast cancer so frequent in The Netherlands?
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1988;14(2):115-22.
1988: Peter Bruning; Johannes M G Bonfrer
Possible relevance of steroid availability and breast cancer.
Annals of the New York Academy of Sciences 1988;538():257-64.
1987: Olaf van Tellingen; Johannes M G Bonfrer; W J Nooyen; Peter Bruning
Improved method for the quantification of aminoglutethimide in urine samples.
Clinica chimica acta; international journal of clinical chemistry 1987;169(1):99-108.
1987: Gemma G Kenter; Johannes M G Bonfrer; A P Heintz
Pretreatment tumour-antigen Ta-4 in serum of patients with squamous cell carcinoma of the uterine cervix.
British journal of cancer 1987;56(2):157-8.
1987: J Hilkens; Johannes M G Bonfrer; V Kroezen; M van Eykeren; W Nooyen; M de Jong-Bakker; Peter Bruning
Comparison of circulating MAM-6 and CEA levels and correlation with the estrogen receptor in patients with breast cancer.
International journal of cancer. Journal international du cancer 1987;39(4):431-5.
1986: J Hilkens; V Kroezen; Johannes M G Bonfrer; M De Jong-Bakker; Peter Bruning
MAM-6 antigen, a new serum marker for breast cancer monitoring.
Cancer research 1986;46(5):2582-7.
1985: J Hilkens; V Kroezen; J Hilgers; Johannes M G Bonfrer; P F Bruning
In vitro serum assay for breast cancer monitoring.
European journal of obstetrics, gynecology, and reproductive biology 1985;19(6):356-7.
1984: Peter Bruning; Johannes M G Bonfrer; M De Jong-Bakker; W Nooyen
Influence of ACTH on aminoglutethimide induced reduction of plasma steroids in postmenopausal breast cancer.
Journal of steroid biochemistry 1984;21(3):293-8.